Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS), 64896-64897 [2019-25467]
Download as PDF
<![CDATA[
64896
Federal Register / Vol. 84, No. 227 / Monday, November 25, 2019 / Notices
information to, persons who seek access
to OGE Form 278 Public Financial
Disclosure Reports, including OGE
Form 278–T Periodic Transaction
Reports, and other covered records. The
form reflects the requirements of the
Ethics in Government Act, subsequent
amendments pursuant to the STOCK
Act, and OGE’s implementing
regulations that must be met by a person
before access can be granted. These
requirements include the address of the
requester, as well as any other person on
whose behalf a record is sought, and
acknowledgement that the requester is
aware of the prohibited uses of
executive branch public disclosure
financial reports. See 5 U.S.C. appendix
105(b) and (c) and 402(b)(1) and 5 CFR
2634.603(c) and (f). Executive branch
departments and agencies are
encouraged to utilize the OGE Form 201
for individuals seeking access to public
financial disclosure reports and other
covered documents. OGE permits
departments and agencies to use or
develop their own forms as long as the
forms collect and provide all of the
required information.
OGE recently revised its OGE/GOVT–
1, Executive Branch Personnel Public
Financial Disclosure Reports and Other
Name-Retrieved Ethics Program Records
system of records. The revisions were
published in the Federal Register on
September 9, 2019, and went into effect
on November 8, 2019. The revisions
included several new and modified
routine uses. The information collected
on the OGE Form 201 is maintained in
the OGE/GOVT–1 Governmentwide
system of records, and the form contains
a Privacy Act statement referencing
OGE/GOVT–1 as required by section
(e)(3) of the Privacy Act. Accordingly,
OGE proposes to update the Privacy Act
statement in accordance with changes to
the OGE/GOVT–1 system of records. No
other changes to the form are proposed.
This change will have no material effect
on the burden to filers.
Request for Comments: OGE is
publishing this first round notice of its
intent to request paperwork clearance
for a proposed modified OGE Form 201.
Agency and public comment is invited
specifically on the need for and
practical utility of this information
collection, the accuracy of OGE’s
burden estimate, the enhancement of
quality, utility and clarity of the
information collected, and the
minimization of burden (including the
use of information technology).
Comments received in response to this
notice will be summarized for and
included with the OGE request for
extension of OMB paperwork approval.
VerDate Sep<11>2014
17:31 Nov 22, 2019
Jkt 250001
The comments will also become a
matter of public record.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Approved: November 20, 2019.
Emory Rounds,
Director, U.S. Office of Government Ethics.
Centers for Disease Control and
Prevention
[FR Doc. 2019–25515 Filed 11–22–19; 8:45 am]
BILLING CODE 6345–03–P
Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP); Notice of Charter
Amendment
This gives notice under the Federal
Advisory Committee Act of October 6,
1972, that the Advisory Committee on
Immunization Practices (ACIP), Centers
for Disease Control and Prevention,
Department of Health and Human
Services, has amended their charter to
include a non-voting liaison
representative; American Immunization
Registry Association. The amended
filing date is October 22, 2019.
FOR FURTHER INFORMATION CONTACT:
Amanda Cohn, M.D., Designated
Federal Officer, Advisory Committee on
Immunization Practices, Centers for
Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE,
Mailstop A27, Atlanta, Georgia 30329–
4027, telephone (404) 639–6039, or fax
(404) 315–4679.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25468 Filed 11–22–19; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Health Statistics
BSC, NCHS. This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-U.S. citizens, pre-approval is
required (please contact Gwen Mustaf,
301–458–4500, glm4@cdc.gov or
Sayeedha Uddin, 301–458–4303, isx9@
cdc.gov at least 4 weeks in advance for
requirements). All visitors are required
to present a valid form of picture
identification issued by a state, federal
in international government. As
required by the Federal Property
Management Regulations, Title 41, Code
of Federal Regulations, Subpart 101–
20.301, all persons entering in or on
Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 78
people.
SUMMARY:
The meeting will be held on
January 9, 2020, 11:00 a.m.–5:30 p.m.,
EDT, and January 10, 2020, 8:30 a.m.–
1:00 p.m., EDT.
ADDRESSES: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
DATES:
FOR FURTHER INFORMATION CONTACT:
Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board
of Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782; telephone (301) 458–4303; email
isx9@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
E:\FR\FM\25NON1.SGM
25NON1
Federal Register / Vol. 84, No. 227 / Monday, November 25, 2019 / Notices
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Considered: The agenda
will include discussion on items per the
scope of the Charter. Day One: The
meeting agenda includes welcome
remarks and a Center update by NCHS
leadership; an update on Patient
Centered Outcomes Research Trust
Fund Projects; presentation of the Nonresponse Bias workgroup report; an
update on National Health and
Nutrition Examination Survey planning;
and discussion on data modernization
in NCHS. Day Two: The meeting agenda
includes discussion of the future
planning for the National Ambulatory
Medical Care Survey and the National
Survey of Family Growth; and an
update on data presentation standards
for rates for vital statistics. Agenda
items are subject to change as priorities
dictate.
Requests to make oral presentations
should be submitted in writing to Gwen
Mustaf, 301–458–4500, glm4@cdc.gov,
or Sayeedha Uddin, 301–458–4303,
isx9@cdc.gov. All requests must contain
the name, address, telephone number,
and organizational affiliation of the
presenter. Written comments should not
exceed five single-spaced typed pages in
length and must be received by
December 26, 2019.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25467 Filed 11–22–19; 8:45 am]
BILLING CODE 4163–18–P
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP20–003, Network of Modeling
Centers to Improve Evidence Base for
Seasonal and Pandemic Influenza
Prevention and Control.
Date: February 25–26, 2020.
Time: 10:00 a.m.–5:00 p.m., EST.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1080, 8 Corporate Square Boulevard,
Atlanta, Georgia 30329–4027.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027; telephone:
(404) 718–8833; email: gca5@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25463 Filed 11–22–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
17:31 Nov 22, 2019
Jkt 250001
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 15–303, Occupational Safety and
Health Education and Research Centers
(ERC).
Date: February 24, 2020.
Time: 6:00 p.m.–8:00 p.m., EST.
Date: February 25–27, 2020.
Time: 8:30 a.m.–5:00 p.m., EST.
Place: Hilton Alexandria Old Town,
1767 King Street, Alexandria, Virginia
22314; telephone: (703) 837–0440.
Agenda: To review and evaluate grant
applications.
For further information contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, CDC, 1095 Willowdale Road,
Morgantown, West Virginia 26505;
telephone: (304) 285–5951; email:
mgoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25464 Filed 11–22–19; 8:45 am]
BILLING CODE 4163–18–P
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00078
Fmt 4703
Sfmt 9990
64897
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 84, Number 227 (Monday, November 25, 2019)]
[Notices]
[Pages 64896-64897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25467]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Health
Statistics (BSC, NCHS)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Health Statistics BSC, NCHS. This meeting is open
to the public; however, visitors must be processed in accordance with
established federal policies and procedures. For foreign nationals or
non-U.S. citizens, pre-approval is required (please contact Gwen
Mustaf, 301-458-4500, [email protected] or Sayeedha Uddin, 301-458-4303,
[email protected] at least 4 weeks in advance for requirements). All
visitors are required to present a valid form of picture identification
issued by a state, federal in international government. As required by
the Federal Property Management Regulations, Title 41, Code of Federal
Regulations, Subpart 101-20.301, all persons entering in or on Federal
controlled property and their packages, briefcases, and other
containers in their immediate possession are subject to being x-rayed
and inspected. Federal law prohibits the knowing possession or the
causing to be present of firearms, explosives and other dangerous
weapons and illegal substances. The meeting room accommodates
approximately 78 people.
DATES: The meeting will be held on January 9, 2020, 11:00 a.m.-5:30
p.m., EDT, and January 10, 2020, 8:30 a.m.-1:00 p.m., EDT.
ADDRESSES: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland
20782.
FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311
Toledo Road, Room 2627, Hyattsville, Maryland 20782; telephone (301)
458-4303; email [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged with providing advice and making
recommendations to the Secretary, Department of Health and Human
[[Page 64897]]
Services; the Director, CDC; and the Director, NCHS, regarding the
scientific and technical program goals and objectives, strategies, and
priorities of NCHS.
Matters To Be Considered: The agenda will include discussion on
items per the scope of the Charter. Day One: The meeting agenda
includes welcome remarks and a Center update by NCHS leadership; an
update on Patient Centered Outcomes Research Trust Fund Projects;
presentation of the Non-response Bias workgroup report; an update on
National Health and Nutrition Examination Survey planning; and
discussion on data modernization in NCHS. Day Two: The meeting agenda
includes discussion of the future planning for the National Ambulatory
Medical Care Survey and the National Survey of Family Growth; and an
update on data presentation standards for rates for vital statistics.
Agenda items are subject to change as priorities dictate.
Requests to make oral presentations should be submitted in writing
to Gwen Mustaf, 301-458-4500, [email protected], or Sayeedha Uddin, 301-458-
4303, [email protected]. All requests must contain the name, address,
telephone number, and organizational affiliation of the presenter.
Written comments should not exceed five single-spaced typed pages in
length and must be received by December 26, 2019.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-25467 Filed 11-22-19; 8:45 am]
BILLING CODE 4163-18-P
